Published in Am J Trop Med Hyg on January 01, 1996
In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob Agents Chemother (2008) 0.94
Antiprotozoal activities of organic extracts from French marine seaweeds. Mar Drugs (2011) 0.92
In vitro antimalarial activity of penduline, a bisbenzylisoquinoline from Isopyrum thalictroides. Antimicrob Agents Chemother (1997) 0.84
In vitro and in vivo potentiation of artemisinin and synthetic endoperoxide antimalarial drugs by metalloporphyrins. Antimicrob Agents Chemother (2000) 0.84
Attitudes and use of medicinal plants during pregnancy among women at health care centers in three regions of Mali, West-Africa. J Ethnobiol Ethnomed (2015) 0.83
Potentiation of artemisinin activity against chloroquine-resistant Plasmodium falciparum strains by using heme models. Antimicrob Agents Chemother (1999) 0.82
Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice. Inflammopharmacology (2010) 0.82
Icacina senegalensis (Icacinaceae), traditionally used for the treatment of malaria, inhibits in vitro Plasmodium falciparum growth without host cell toxicity. Malar J (2011) 0.82
Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin. Antimicrob Agents Chemother (2012) 0.80
Evaluation of the anti-inflammatory property of the extract of Combretum micranthum G. Don (Combretaceae). Inflammopharmacology (2003) 0.77
Potential antimalarials from African natural products: A reviw. J Intercult Ethnopharmacol (2015) 0.77
In vitro and in vivo anti-malarial activity of plants from the Brazilian Amazon. Malar J (2015) 0.75
The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients. Proc Natl Acad Sci U S A (1993) 2.94
Prognostic performance and customization of the SAPS II: results of a multicenter Austrian study. Simplified Acute Physiology Score. Intensive Care Med (1999) 2.61
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM). Intensive Care Med (2012) 2.49
[Change in therapy target and therapy limitations in intensive care medicine. Position paper of the Ethics Section of the German Interdisciplinary Association for Intensive Care and Emergency Medicine]. Anaesthesist (2013) 2.14
The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J Virol (1996) 1.85
Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem (2001) 1.81
Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse. Int J Immunopharmacol (1979) 1.65
Evaluation of the logistic organ dysfunction system for the assessment of organ dysfunction and mortality in critically ill patients. Intensive Care Med (2001) 1.61
Evaluation of an interdisciplinary data set for national intensive care unit assessment. Crit Care Med (1999) 1.56
Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther (2008) 1.56
Sex-related differences in acetazolamide-induced cerebral vasomotor reactivity. Stroke (1996) 1.45
Assessment of functional knee bracing: an in vivo three-dimensional kinematic analysis of the anterior cruciate deficient knee. Clin Biomech (Bristol, Avon) (2001) 1.44
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J Clin Microbiol (1995) 1.44
Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J Biol Chem (1990) 1.30
V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology (1993) 1.24
Enzyme coupling method on calibrated nylon spheres: application to the selective trypsinization of histones in chromatin. Biochem Biophys Res Commun (1990) 1.23
Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model. Antimicrob Agents Chemother (1996) 1.22
Atypical strains of Candida albicans recovered from AIDS patients. J Med Vet Mycol (1997) 1.15
Genetic polymorphism of Aspergillus fumigatus in clinical samples from patients with invasive aspergillosis: investigation using multiple typing methods. J Clin Microbiol (2001) 1.15
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob Agents Chemother (1994) 1.14
Idiopathic adhesive capsulitis of the shoulder: a review. Knee Surg Sports Traumatol Arthrosc (2007) 1.12
N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem Biophys Res Commun (1994) 1.11
Simultaneous detection of gastrointestinal pathogens with a multiplex Luminex-based molecular assay in stool samples from diarrhoeic patients. Clin Microbiol Infect (2013) 1.07
N'Dribala (Cochlospermum planchonii) versus chloroquine for treatment of uncomplicated Plasmodium falciparum malaria. J Ethnopharmacol (2003) 1.06
Incidence and outcome of weaning from mechanical ventilation according to new categories. Eur Respir J (2009) 1.06
Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid. Virology (1989) 1.04
Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency. AIDS (1990) 1.04
A randomized, double-blind study on the efficacy and safety of a practical three-day regimen with artesunate and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa. Trans R Soc Trop Med Hyg (2003) 1.03
Multicentric epidemiological study of Aspergillus fumigatus isolates by multilocus enzyme electrophoresis. J Clin Microbiol (1996) 1.02
[Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures]. Pathol Biol (Paris) (1992) 1.01
Thymidine and 3'-azido-3'-deoxythymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. A study of both anabolic and catabolic pathways. J Biol Chem (1992) 1.00
N omega-hydroxy-L-arginine, a reactional intermediate in nitric oxide biosynthesis, induces cytostasis in human and murine tumor cells. Biochem Biophys Res Commun (1993) 0.98
Genetic structure of Candida glabrata populations in AIDS and non-AIDS patients. J Clin Microbiol (2002) 0.97
Evaluation of the susceptibility of dermatophytes to antifungal drugs: a new technique. J Med Vet Mycol (1996) 0.97
In vitro antiplasmodial activity of extracts of Alchornea cordifolia and identification of an active constituent: ellagic acid. J Ethnopharmacol (2002) 0.97
An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res Immunol (1990) 0.97
Ratios of observed to expected mortality are affected by differences in case mix and quality of care. Intensive Care Med (2000) 0.97
Frontal and temporal functional connections of the living human brain. Eur J Neurosci (2007) 0.96
Molecular typing of Aspergillus fumigatus strains by sequence-specific DNA primer (SSDP) analysis. FEMS Immunol Med Microbiol (1997) 0.96
[Syringomyelia as a rare cause of respiratory insufficiency requiring ventilation]. Dtsch Med Wochenschr (1994) 0.95
Antiplasmodial activity of plant extracts used in west African traditional medicine. J Ethnopharmacol (2000) 0.94
Composition and antimalarial activity in vitro of volatile components of Lippia multiflora. Phytochemistry (1995) 0.93
Localization of ribosomal proteins on the surface of mammalian 60S ribosomal subunits by means of immobilized enzymes. Correlation with chemical cross-linking data. Biochem Biophys Res Commun (1987) 0.93
Combination of three typing methods for the molecular epidemiology of Aspergillus fumigatus infections. European Research Group on Biotype and Genotype of Aspergillus. J Med Microbiol (1999) 0.92
Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum. Parasite (2007) 0.92
Production and characterization of monoclonal antibodies against human thyroglobulin. Hybridoma (1985) 0.91
Conformation of chromatin oligomers. A new argument for a change with the hexanucleosome. Eur J Biochem (1981) 0.91
A 37-kilodalton glycoprotein of Babesia divergens is a major component of a protective fraction containing low-molecular-mass culture-derived exoantigens. Infect Immun (1995) 0.90
Antigenic domains on the human thyroglobulin molecule recognized by autoantibodies in patients' sera and by natural autoantibodies isolated from the sera of healthy subjects. Clin Immunol Immunopathol (1987) 0.90
Ribosomal proteins S2, S6, S10, S14, S15 and S25 are localized on the surface of mammalian 40 S subunits and stabilize their conformation. A study with immobilized trypsin. FEBS Lett (1988) 0.90
CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals. J Immunol (2001) 0.90
In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis. Mycoses (1989) 0.90
Confirmation of immunogenic consensus sequence HIV-1 T-cell epitopes in Bamako, Mali and Providence, Rhode Island. Hum Vaccin (2006) 0.90
Role of histones H1 and H3 in the maintenance of chromatin in a compact conformation. Study with an immobilized enzyme. FEBS Lett (1983) 0.90
Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity. J Ethnopharmacol (2007) 0.90
[Decrease in chloroquine resistant Plasmodium falciparum in the Abidjan region (Ivory Coast)]. Med Trop (Mars) (1993) 0.89
Study of chromatin organization with trypsin immobilized on collagen membranes. Biochem Biophys Res Commun (1983) 0.89
Large scale survey of bovine babesiosis due to Babesia divergens in France. Vet Rec (1995) 0.89
A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy. Can J Microbiol (1982) 0.89
Contribution of molecular diagnosis to the management of cutaneous leishmaniasis in travellers. Clin Microbiol Infect (2014) 0.89
Antimalarial activity in vitro of Cochlospermum tinctorium tubercle extracts. Trans R Soc Trop Med Hyg (1995) 0.89
Demonstration of Helicobacter pylori-like organisms in the gastric mucosa of captive exotic carnivores. J Comp Pathol (1997) 0.89
Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages. Infect Immun (1992) 0.89
Analysis of immune responses of different hosts to Babesia divergens isolates from different geographic areas and capacity of culture-derived exoantigens to induce efficient cross-protection. Infect Immun (1991) 0.88
Outcome in patients with intracerebral hemorrhage: predictors of survival. Wien Klin Wochenschr (2000) 0.88
High-performance liquid chromatographic analysis of the unusual pathway of oxidation of L-arginine to citrulline and nitric oxide in mammalian cells. J Chromatogr (1991) 0.88
Disseminated Ochroconis gallopava infection in a heart transplant patient. Transpl Infect Dis (2013) 0.88
Antimalarial activity of simalikalactone E, a new quassinoid from Quassia amara L. (Simaroubaceae). Antimicrob Agents Chemother (2009) 0.88
Mupirocin resistance is not an inevitable consequence of mupirocin use. J Hosp Infect (2011) 0.87
Multicentric genetic study of Candida albicans isolates from non-neutropenic patients using MLEE typing: population structure and mode of reproduction. Mycoses (2000) 0.87
Antigen-capture ELISA for viral haemorrhagic septicaemia virus serotype I. J Virol Methods (1990) 0.87
Effect of ribonuclease T1 on ribosomal subunits of rat liver. Nucleic Acids Res (1976) 0.87
In vitro antimalarial activity and cytotoxicity of cochlospermum tinctorium and C. planchonii leaf extracts and essential oils. Planta Med (1999) 0.87
Etiology of otospongiotic sensorineural losses. Am J Otol (1989) 0.86
Simultaneous carriage of Candida albicans strains from HIV-infected patients with oral candidiasis: multilocus enzyme electrophoresis analysis. FEMS Microbiol Lett (1996) 0.86
Multilocus enzyme electrophoresis analysis of Aspergillus fumigatus strains isolated from the first clinical sample from patients with invasive aspergillosis. EBGA Network. European Research Group on Biotype and Genotype of Aspergillus. J Med Microbiol (2000) 0.86
Control of Candida albicans vaginitis in mice by short-duration butoconazole treatment in situ. Mycoses (1994) 0.86
Accessibility and structural role of histone domains in chromatin. biophysical and immunochemical studies of progressive digestion with immobilized proteases. J Biomol Struct Dyn (1990) 0.86
Fate of two 14C labelled muramyl peptides: Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm and Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala-D-Ala in mice. Evaluation of their ability to increase non specific resistance to Klebsiella infection. Int J Immunopharmacol (1982) 0.85
Separability of enzymes of the common aromatic biosynthetic pathway in Mycobacterium phlei. Biochimie (1974) 0.85
Studies on medicinal plants of Ivory Coast: investigation of Sida acuta for in vitro antiplasmodial activities and identification of an active constituent. Phytomedicine (2004) 0.85
Perinuclear cytoskeleton of acrosome-less spermatids in the blind sterile mutant mouse. Tissue Cell (1992) 0.85
Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model. J Med Vet Mycol (1992) 0.85
In vitro antiplasmodial activity of stem and root extracts of Nauclea latifolia S.M. (Rubiaceae). J Ethnopharmacol (1998) 0.85